The Effect of Injectable Platelet-Rich Fibrin in Peri-implant Soft Tissue

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorKutahya Health Sciences University

About this trial

An inadequate amount of peri-implant soft tissue results in more plaque accumulation around the implants, peri-implant mucositis, marginal bone loss, mucosal recession, and/or attachment loss. In the literature, there are studies evaluating the application of injectable platelet-rich fibrin to the gingiva and oral mucosa around teeth, but injectable platelet-rich fibrin application around implants has not been encountered. This study aimed to evaluate the effect of subgingival and submucosal application of injectable platelet-rich fibrin on peri-implant soft tissue phenotype in patients with inadequate peri-implant soft tissue phenotype.The study will include 80 systemically healthy and non-smoking patients/implants older than 18 years of age with insufficient peri-implant keratinized mucosa width and mucosal thickness who applied to Kütahya University of Health Sciences, Faculty of Dentistry, Department of Periodontology. There are two study groups according to peri-implant mucosa phenotype: Thin phenotype and thick phenotype. All patients will undergo the same procedure of injectable platelet-rich fibrin application

Eligibility criteria

Qualifiers

be over 18 years old

The patient does not have any systemic disease

Patients who do not smoke or who smoke less than 10 cigarettes

Peri-implant keratinized mucosa width less than 2 mm

Disqualifiers

Being out of the defined age group

Any systematic contraindication for periodontal surgery

Patients who smoke more than 10 cigarettes per day

Patients with adequate peri-implant keratinized mucosa width and mucosal thickness

Trial design

Treatments tested in this trial

  • Platelet rich fibrin

Treatment groups

80 Participants
are divided into 2 treatment groups